Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials
From MaRDI portal
Publication:6644034
DOI10.1111/rssc.12598MaRDI QIDQ6644034
Mourad Tighiouart, J. L. Jiménez
Publication date: 27 November 2024
Published in: Journal of the Royal Statistical Society. Series C. Applied Statistics (Search for Journal in Brave)
drug combinationadaptive randomizationBayesian phase I--II designcontinuous dose levelsescalation with overdose control (EWOC)
This page was built for publication: Combining cytotoxic agents with continuous dose levels in seamless phase I--II clinical trials